Talasaz AmirAli's Form 4 filing
Guardant Health, Inc. (GH) · filed May 22, 2026
- Accession no.
- 0001753159-26-000012
- Filed
- May 22, 2026
- Trade date
- May 20, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions and 0 derivative transactions. Open-market sales total $23.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Talasaz AmirAliCIK 0001753159 | Director, Officer (Co-Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | Common Stock | SSaleDisposed | −200 | $100.95 | −$20,190 | 2,096,304 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −900 | $102.57 | −$92,313 | 2,095,404 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −1,366 | $103.82 | −$141,818.12 | 2,094,038 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −11,919 | $105.01 | −$1,251,614.19 | 2,082,119 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −1,200 | $105.88 | −$127,056 | 2,080,919 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −21,171 | $106.99 | −$2,265,085.29 | 2,059,748 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −33,069 | $108.11 | −$3,575,089.59 | 2,026,679 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −9,852 | $108.97 | −$1,073,572.44 | 2,016,827 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −28,908 | $110.10 | −$3,182,770.8 | 1,987,919 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −37,163 | $111.14 | −$4,130,295.82 | 1,950,756 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −37,900 | $112.02 | −$4,245,558 | 1,912,856 | Indirect | |
| May 20, 2026 | Common Stock | SSaleDisposed | −26,352 | $112.76 | −$2,971,451.52 | 1,886,504 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.